The Targeted Approach: How Biologic Arthritis Therapies and Disease-modifying Antirheumatic Drugs (DMARDs) Are Redefining Remission in Rheumatoid Arthritis
The advent of Biologic arthritis therapies marked a paradigm shift in the treatment of rheumatoid arthritis. For the first time, therapies were developed that could precisely target and neutralize specific molecules in the inflammatory cascade that drives the disease. This targeted approach, often used in combination with Disease-modifying antirheumatic drugs (DMARDs) , has...
0 Comments 0 Shares 330 Views 0 Reviews